What currency does Inovio Pharmaceuticals (Ino) use?

Currency in USD Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript November 9, 2023 Inovio Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.13 EPS, expectations were $-0.13.

Is ino a good stock to buy in 2022?

[Read more] In 2022, INO's revenue was $10.26 million, an increase of 478.23% compared to the previous year's $1.77 million. Losses were -$279.82 million, -7.85% less than in 2021. According to one analyst, the rating for INO stock is "Hold" and the 12-month stock price forecast is $2.0.

Should you buy io-3107 (Ino) stock?

According to one analyst, the rating for INO stock is "Hold" and the 12-month stock price forecast is $2.0. Achieved significant progress with lead product candidate, INO-3107 Received Breakthrough Therapy designation from U.S. Food and Drug Administration (FDA) as a potential treatment for Recurren...

Is Ino trading at a 60% discount?

INO is trading at a 60% discount. Is it the right time to buy, sell, or hold? Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if INO is a good fit for your portfolio.